Honors Thesis

Honors Program

5-5-2020

The Influence of Anti-Inflammatory Diets on the Reduction of
Symptoms of Inflammatory Bowel Disease
Kelly Stanton
kstanto3@lion.lmu.edu

Follow this and additional works at: https://digitalcommons.lmu.edu/honors-thesis
Part of the Human and Clinical Nutrition Commons

Recommended Citation
Stanton, Kelly, "The Influence of Anti-Inflammatory Diets on the Reduction of Symptoms of Inflammatory
Bowel Disease" (2020). Honors Thesis. 237.
https://digitalcommons.lmu.edu/honors-thesis/237

This Honors Thesis is brought to you for free and open access by the Honors Program at Digital Commons @
Loyola Marymount University and Loyola Law School. It has been accepted for inclusion in Honors Thesis by an
authorized administrator of Digital Commons@Loyola Marymount University and Loyola Law School. For more
information, please contact digitalcommons@lmu.edu.

The Influence of Anti-Inflammatory Diets on the Reduction of Symptoms of Inflammatory
Bowel Disease

The Influence of Anti-Inflammatory Diets on the Reduction of Symptoms of
Inflammatory Bowel Disease

A thesis submitted in partial satisfaction
of the requirements of the University Honors Program
of Loyola Marymount University

by

Kelly Stanton
May 5, 2020

Anti-Inflammatory Diets Influencing IBD

2

The Influence of Anti-Inflammatory Diets on the Reduction of Symptoms of Inflammatory
Bowel Disease

Kelly Stanton
HNRS-4000
Dr. Almstedt
May 5, 2020

Anti-Inflammatory Diets Influencing IBD

3

Introduction
A person’s diet is a highly modifiable facet of lifestyle someone can change in order to
alter their internal bodily processes. One of these processes is inflammation. While inflammation
is beneficial as part of an acute immune response, it can become detrimental to a person’s health
if it becomes chronic. There are many dietary factors that can be examined in order to avoid or
diminish chronic, unwarranted, inflammation. This paper focuses on how people can change
their dietary patterns to control symptoms of Inflammatory Bowel Disease (IBD), an immunemediated inflammatory condition that is heavily influenced by excessive inflammation in the
digestive tract. Day-to-day dietary changes that can create an anti-inflammatory effect include an
overall elimination technique through following The Autoimmune Protocol, limiting residue
within the diet, and meeting adequate requirements of omega-3 polyunsaturated fatty acids (n-3
PUFAs).
Inflammation and its Regulation
Inflammation is a normal response within the body, as an integral part of the innate
immune system. The initiation of inflammation aims to eliminate pathogens that may cause
tissue damage. Inflammation is essential in the immune response as it allows for many types of
immune cells, such as neutrophils, to migrate to an infected area and recognize a pathogen they
need to attack. While this beneficial reaction is meant to be acute, some people can experience
chronic inflammation as well. This chronic inflammation can cause tissue damage and, if left
untreated, organ damage. This may seem counterintuitive due to the fact that inflammation is a
mechanism of the immune system, used to protect the body, but a response is not always
warranted (Bauman, 2017).
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One common reason for unwanted inflammation in the body, as seen in many chronic
diseases, is the formation of immune complexes. These immune complexes are constructed when
multiple antibody-antigen units bind to each other and become a mesh-like network (Bauman,
2017). If these complexes are large, they can get stuck in blood vessels, and thus activate an
immune response, inducing inflammation, even though there is no pathogen threatening a
person’s tissues. Over time, these immune complexes can cause chronic, widespread,
inflammation (Bauman, 2017). This is only one of the many ways in which there is an abnormal
T cell immune response stimulated within the body. There are many causes of abnormal T cell
function, which typically lead to inflammation. When T cells are not regulated correctly, they
begin to recognize a pathogen, or even non-pathogenic cells, as foreign, and then induce more
inflammation with a positive feedback loop (Bauman, 2017). These abnormalities cause the type
of inflammation that worsens chronic diseases. One chronic disease that displays a dysregulation
of T cells is IBD. In IBD, the microbiome of the gut is thrown off balance and the lack of
diversity of bacteria in this microbiome can lead to the misregulation of T cells (Kostic et al.,
2014).
The microbiome is the collection of microorganisms such as bacteria, fungi, genetic
material, or even viruses that live in and on your body (Bauman, 2017). Each individual has a
unique microbiome within their gastrointestinal (GI) tract, or their gut. This microbiome can help
synthesize vitamins, absorb vitamins and minerals, digest food, enhance nutrition, inhibit the
growth of pathogens, prevent infection, and even keep your immune system healthy.
Fermentation is carried out by the bacterial colonies that are part of this microbiome.
Fermentation is the process by which microorganism such as bacteria in the gut break down
foods such as carbohydrate or fiber into usable acids such as short-chain fatty acids. The
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byproducts of fermentation by the gut microbiota are helpful in providing energy for epithelial
cells lining the GI tract and can aid in enhancing the integrity of the epithelial barrier of the gut
(Bauman, 2017). This epithelial integrity is important because it prevents any leakage of contents
from the gut inside the body, which may cause an immune response led by T cells. Gut dysbiosis
occurs when this microbial community is altered in a way that decreases the number and
diversity of bacteria. Gut dysbiosis is associated with many chronic health conditions, one of
which is IBD (Bauman, 2017).
IBD
IBD is a group of disorders that lead to the chronic inflammation of the GI tract. Two
types of IBD include Chron’s Disease and Ulcerative Colitis. Chron’s Disease mainly affects the
final portion of the small intestine but can ultimately affect any part of the GI tract. Ulcerative
Colitis is defined by the long-term inflammation and formation of ulcers in the lining of the large
intestine and rectum (Kostic et al., 2014). A major factor in the possible development of IBD is
the microbial community of the gut. It is suggested that IBD can be due to the dysregulation of
the mucosal immune system as a result of specific changes in the microbiome (Knox et al.,
2019).This then causes dysbiosis in the intestinal lining, which leads to chronic
inflammation. Dysbiosis in the lining of the intestines begins with a genetic abnormality that
makes the host more susceptible and is followed by the ways in which the microbiome of the gut
responds to its environment (Knox et al., 2019).
Until recently, IBD was thought of as an autoimmune disease because it was originally
assumed that the chronic inflammation seen with this condition was due to the immune system
attacking itself, but this is not actually the case (Kostic et. al., 2014). Instead, the microbiome of
the gut is attacking “harmless” viruses, bacteria, or food products that pass through the GI tract,

Anti-Inflammatory Diets Influencing IBD

6

which is causing the chronic swelling and damage to the intestines that characterize IBD. Experts
now believe that IBD results from altered interactions between intestinal microbes and the
mucosal immune system (Kostic et. al., 2014). Because of these factors, IBD is no longer
classified as an autoimmune disease. Instead, it is considered an immune-mediated inflammatory
disease (Knox et al., 2019).
Immune-mediated inflammatory diseases lack any definitive etiology. They are identified
by common inflammatory pathways leading to inflammation, which is triggered by a
dysregulation of the normal immune response. In the case of IBD, this dysregulation is cause by
dysbiosis within the gut. These diseases have been seen to occur in people who have specific
genetic mutations which make them more susceptible when they have an overactive
immunological response which is initiated and then later reactivated by exposure to
environmental stimuli. The presence of overactive immunological responses makes these
diseases similar to autoimmune diseases because the host has an overactive immune response,
but they are different because the response is not to a stimulus that originates within the body,
but one that comes from the environment (Knox et al., 2019).
Dietary Intake and IBD
Recent studies have shown that the rates of patients with IBD is increasing greatly over
the years, suggesting that genetics and a person’s immune response are not the only major factors
that determine whether or not a person develops this disease (Kostic et al., 2014). Instead,
environment is playing a large role in this determination, and diet is one way in which a person
can change the environment and the microbiome which resides in their digestive system. Longterm dietary decisions impact the types of microorganisms that grow and flourish in a person’s
gut, whether they be healthy or not (Kostic et al., 2014). Because of the large environmental
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impact on IBD, a person’s dietary patterns can very easily influence inflammation and have a
negative impact on their symptoms and reoccurrence of IBD. Luckily, a healthier and more
structured diet can be a possible solution to help decrease systemic inflammation and manage, or
even decrease, symptoms of IBD (Richards et al., 2016). The focus of dietary patterns used to
decrease gut inflammation should be on anti-inflammatory foods. This includes, but is not
limited to, foods allowed through an elimination-based diet, a focus on nutrient-dense foods,
lowering the amount of residue in the diet and meeting adequate requirements of n-3 PUFAs.
Nutrient dense foods contain high amounts of nutrients, such as essential vitamins and minerals,
and have relatively low calories compared to other foods in the same proportions.
A major contributing factor of dietary patterns which increase systemic inflammation has
to do with a person’s gut microbiome. Although humans are born with very unique microbiomes,
these microbiomes constantly adapt over time, and diet can play a central role in the alterations
within the microbiome (Richards et al., 2016). A person’s digestive tract is one of many large
mucosal surface areas within the body, which means it is also home to many T cells and other
immunoregulatory cells. It has been recognized that what a person puts into their body can affect
the microbiome of their gut by changing the types of bacteria that may be growing there
(Richards et al., 2016). The specific bacteria that grow in a person’s gut can then affect the health
of these mucosal layers, which can help maintain healthy function of T cells and other
immunoregulatory cells.
Autoimmune Protocol Diet
The Autoimmune Protocol Diet (AIP) is a dietary protocol meant to mimic ideas behind
following the “Paleolithic Diet”, to eliminate any foods that do not seem to be tolerated well by
the bacteria in many people’s gut microbiome and may cause it to be compromised. The main
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goal of the AIP is to eliminate any factors of the Western diet that cause inflammation or other
immune responses and to replace them with more nutrient-dense foods that have healthier effects
on our gut microbiome and body in general. While IBD is not an autoimmune disease, it is
triggered by a dysregulation of the body’s normal immune response and acts like an autoimmune
disease of the gut.
The first part of this protocol is considered an elimination phase, in which a person cuts
out many foods within their diet that may be harming their microbiome (Konijeti et al., 2017).
The food groups that are eliminated during this initial phase include grains, legumes, eggs, dairy,
nuts and seeds, coffee, alcohol, refined/processed sugars, nightshades, industrial seed oils, as
well as food additives and nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or
ibuprofen. Nightshades are foods that may appear healthy at first but are not tolerated well by all
individuals, such as tomatoes, eggplant, peppers, and more. During the elimination phase, it is
essential for participants to also focus on eating nutrient-dense foods and probiotics, and to pay
attention to how their foods are prepared to avoid losing nutrients. Some of the foods that are still
options for people to eat once they are going through this elimination phase would be lean meats
and fish, vegetables (excluding nightshades), fruits, plant-based milks such as coconut milk,
fermented foods, and other foods which do not fall into the categories listed above. The second
phase of this diet is a maintenance phase, when a person should continue with this new diet from
the initial phase until their symptoms improve. At this point, a person moves into the
reintroduction phase by slowly reinstating specific foods in stages to determine which foods or
food groups are symptomatic triggers (Konijeti et al., 2017).
A study done by Konijeti et al. (2017) investigated how the AIP specifically affects IBD.
Although this study only followed participants during the elimination phase (6 weeks) and the
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maintenance phase, not the reintroduction phase, the results were still very informative. By the
end of the 6-week elimination phase, 11 out of 15 (73%) of the participants were in remission
from IBD altogether. This is a significant discovery, especially considering that the most
effective IBD drug treatments only have an average of a 50% remission rate (Konijeti et al.,
2017). Along with these results, there was also a reduction in fecal calprotectin (FC) and
refinement in mucosal inflammation as viewed through endoscopy in patients after following this
diet. FC is used as a measure to determine the number of neutrophils that travel to the intestinal
mucosa, which is caused by inflammation (Konijeti et al., 2017). So, this means that,
implementing this dietary change can help people with IBD alleviate some of their symptoms,
and possibly even move into remission.
In 2019, a follow-up study was performed by Chandrasekaran et al. This was a
randomized control trial which was performed on 9 participants with Crohn’s disease , and 6
who had Ulcerative Colitis that was focused on examining the quality of life changes between
participants. Like the previous study, this new trial examined participants through the 6-week
elimination phase of the AIP, in which certain foods were eliminated in a staged fashion over
time. It also followed participants for a 5-week maintenance phase after the eliminations, in order
to assess the outcomes of the eliminations. Participants filled out the Short Inflammatory Bowel
Disease Questionnaire (SIBDQ) at baseline and weeks 3, 5, 9, and 11 to assess how the dietary
changes may have improved their quality of life. The results of this study showed that in both
Chron’s disease and ulcerative Colitis patients, while the questionnaire scores were different
between these two subgroups, the scores for each subgroup significantly improved by week 11 of
the trial. Results of the improved quality of life were significant as early as week 3 of the dietary
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intervention, showing how diet can not only help alleviate symptoms of such an uncomfortable
disease, but also improve a patient’s quality of life (Chandrasekaran et al., 2019).
The AIP diet can be followed in contrast to diets like the Western diet which include
excess of certain food groups, and are specifically high in saturated fats, which have been
commonly linked to increased systemic inflammation. A high-fat Western diet leads to extra fat
stores and adipose tissue within the body which chronically manipulate regulatory T cells of the
immune system. As explained previously, the dysregulation of these regulatory T cells can create
an unwanted inflammatory response, and in this case, it creates a low-grade response. This
would not typically be a problem, except in the case of diet. Consuming a Western diet is a
chronic pattern that makes this inflammatory response chronic as well (Manzel et al., 2014).
Without changes in dietary habits, there is no change within the body to help with this
chronically increasing inflammation. Even if a person decides to change their eating habits for a
week or two, this will not be enough. The inflammation stimulated by an excessively high-fat
diet stems mainly from the adipose tissue cells that form within the person’s body (Manzel et al.,
2014). To decrease these inflammatory responses, a person needs to change their dietary habits
for an extended period of time in order to give their bodily systems time to adjust.
Low Residue Diets
One food component that has been shown to have a great effect on the microbiome and
the mucosal layers of the gut is fiber. Although the body cannot digest fiber, the gut bacteria can
ferment some forms of fiber, creating helpful metabolites such as short-chain fatty acids
(SCFAs) (Richards et al., 2016). SCFA have anti-inflammatory effects by controlling the number
of regulatory T cells and their functioning abilities within the colon. Along with direct gut health,
the article written by Richards et al. (2016), explains how SCFAs can help increase the
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generation of T regulatory cells via epigenetic effects. This allows immune cells to work
throughout the whole body in order to have more power over autoreactive lymphocytes, which
can help prevent the development of or decrease the symptoms of immune-mediated
inflammatory diseases (Richards et al., 2016).
SCFAs can help keep the mucosal layer of the gut healthy. Without an adequate
production of SCFA, the function of the intestinal mucosal barrier will begin to break down,
making it “leaky” (Richards et al., 2016). When there is a leakage in this barrier, an immune
response will be created by T cells and immunoglobulin-A (IgA) antibodies. This immune
response will also create an increase in inflammation. Along with this immediate immune
response, there is a greater likelihood that pathogenic bacteria will attach to the gut mucosal
surface when it is not protected as well. This will also cause an inflammatory immune response
(Dolan & Chang, 2017). While there is currently much controversial evidence as to whether or
not leaky gut syndrome is a real diagnosis, there is evidence that shows that permeability of the
intestinal lining does still occur and lead to inflammation (Fasano, 2012).
There are many different types of fiber, and it is very important for people with IBD to
know which types of fiber they are eating in order to gain the desired effects. A study by Kuo
(2013), compared previous clinical trials in which fermentable fibers were incorporated into the
diet and inflammatory markers within the body were measured. Kuo’s review explained the
previous discrepancies as to why certain studies were not showing significant results and
ultimately suggested that an introduction of adequate amounts of fermentable fiber into a
person’s diet decreases the number of inflammatory markers present (2013). Fermentable fibers
can be found mainly in beans and legumes. The current adequate intake recommendation of fiber
is between 25-38 grams per day of total fiber (Institute of Medicine, 2005). Along with
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fermentable fiber, soluble fiber has also been seen to decrease inflammation. A study done by
Morrison et al. in 2019, demonstrated how diets without adequate soluble fiber were shown to
increase systemic inflammation and to promote a poor nutritional environment of the gut in
mice. This study was performed because previous research overlooked the role of soluble fiber
on different diseases. In this study, mice were transferred from a chow diet to a low-soluble fiber
diet. This shift was seen to increase the systemic inflammation of the rodents, and they lost
specific taxa of bacteria in the gut microbiome which were important to the environmental health
of the gut (Morrison et al., 2019).
The low-residue diet focuses on digestibility of food intake and emphasizes consumption
of different types of fiber. In the case of a low-residue diet, residue is an umbrella term for any
type of food that is poorly digested (Hwang et al., 2014). While people automatically assume that
this means fiber as a whole and attempt to cut fiber out of their diet completely, it specifically
refers to insoluble fibers. Soluble and fermentable fibers are still beneficial to digestion and are
recommended within a person’s diet. While this is the case, many foods that have one type of
fiber also have others, this is why a person following a low-residue diet should limit their
insoluble fiber intake and they should try to focus on what kind of fiber is in the foods they are
preparing. Studies on this diet suggest that a lower recommendation of fiber, specifically 10-15
grams per day, is more beneficial in order to avoid taking in too much insoluble fiber which can
be found in foods that also contain soluble and fermentable fiber types. Beneficial soluble fibers
can be found in food such as oatmeal, peeled fruits, nuts, seeds, and more (Hwang et al., 2014).
Below is a chart that shows how many of the foods that are high in soluble fiber, have a large
amount of insoluble fiber as well.
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Table 1: Shows the amount of soluble and insoluble fiber in high fiber foods (adapted from
Jackson GI Medical, 2020)
Food
Serving Size
Total Fiber
Soluble Fiber
Insoluble fiber
(Grams)
(Grams)
(Grams)
Apple (Peeled)
1 Apple
2.40
0.70
1.70
Black Beans

1 Cup

5.30

1.40

3.90

Broccoli (Fresh

1 Cup

4.60

2.30

2.30

1 Cup

6.40

3.90

2.50

Carrots (Raw)

1 Cup

3.30

1.60

1.70

Green Peas

1 Cup

8.80

2.60

6.20

Lentils

1 Cup

7.30

1.10

6.40

Lima Beans

1 Cup

13.20

7.00

6.20

Oatmeal

1 Cup

4.00

1.90

2.10

Soybeans

1 Cup

30.40

13.70

16.70

1 Cup

13.40

2.70

10.70

1 Slice of Bread

0.20

0.10

0.10

Cooked)
Brussel Sprouts
(Cooked)

(Cooked)

(Cooked)

(Roasted)
Sunflower
Seeds
Whole Wheat

Omega-3 Enriched Diets
Another main element of the typical Western diet that leads to systemic inflammation is
the overconsumption of saturated fatty acids (SFA). These types of fatty acids can typically be
found in animal foods such as different types of meat or high-fat dairy products. As mentioned
before, dietary habits have a direct effect on the microbiome within a person’s gut. High-fat
foods, specifically foods high in saturated fat, increases the release of lipopolysaccharides (LPS)
from the gut bacteria into the bloodstream and can lead to metabolic endotoxemia. This then
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causes the activation of toll-like receptor-4 (TLR4) complexes and their subsequent
inflammatory pathways. This can lead to a more chronic form of inflammation, which is the type
of inflammatory reaction that is seen in IBD and other chronic inflammatory diseases (Rocha et
al., 2016).
One way to reduce systemic inflammation is to lower consumption of SFAs. While this
can help with the problem of systemic inflammation, many people replace these fats with
unhealthy, high glycemic index carbohydrates. A healthier, and even anti-inflammatory,
alternative to this approach is to replace SFAs with unsaturated fatty acids. More specifically, a
person should replace SFAs with n-3 PUFAs which have a very positive effect of antagonizing
unnecessary systemic inflammation (Calder & Grimble, 2002).
While it is important to consume both n-6 and n-3 PUFAs, many people do not consume
these products in correct proportions (Simopoulos, 2008). Most people eat many more n-6s which
is most likely due to their abundance in commonly consumed foods such as nuts, seeds, and oils
(Mayo Clinic, 2019). Fish and fish oils are the main sources of n-3s, which many people do not
incorporate into their diets enough. In order to eat the correct proportions of n-3s to n-6s, the
World Health Organization recommends that people incorporate two servings of fish into their
diet each week as an adequate source of n-3s (Kris-Etherton et al., 2009). It has also been
determined that n-6s compared to n-3s should be consumed in a ratio of 4:1, so the
recommended amount of n-6s that a person should eat will depend on their n-3 intake
(Simopoulos, 2008).
The common discrepancy between how much of each nutrient is eaten is important
because n-6s increase the amount of arachidonic acid in the body, and n-3s increase
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Arachidonic acid increases a
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person’s eicosanoids which can help regulate the intensity and duration of inflammation during
an immune response (Calder & Grimble, 2002). These eicosanoids can have many different
effects, some of which can be pro-inflammatory, and others which can be immunosuppressive. In
contrast to this, EPA from fish oils has been seen to competitively inhibit the oxygenation of
arachidonic acid. After the inhibition, EPA-derived eicosanoids are produced instead of the
eicosanoids produced by arachidonic acid. These EPA eicosanoids have anti-inflammatory
effects and they can enhance immune function (Calder & Grimble, 2002).
There are two separate ways in which n-3 and n-6 PUFAs battle over whether or not an
inflammatory response will be induced. These two methods are through the activation of TLRs
and the formation of different types of eicosanoids. A study done by Weatherill et al. in 2005
was aimed at determining whether or not either saturated or unsaturated fatty acids alter immune
responses as a result of the regulation of TLR signaling pathways and the genes they helped
express within dendritic cells. Although the main aim of this study was not focused on the
inflammatory effects of these fatty acids, these responses were discussed in the results. This
study compares the SFA lauric acid, and the n-3 PUFA, DHA. Within this study, it was
determined that lauric acid activates TLR4 and DHA was an antagonist to this activation. The
activation of these TRL4s is the main mechanism of initiating an immune response within the
body, and the main component of this immediate immune response is inflammation. This is why
it is important to recognize that DHA fails to stimulate unhealthy receptors, but it also
antagonizes their activation. By incorporating more n-3 PUFAs into the diet, a person can reduce
any systemic inflammation which may be causing them harm. (Weatherill et al., 2005)
Like the study explained above, Calder and Grimble (2002) directly examined the effects
of n-3 PUFA supplementation and its effects on diseases that may owe their pathogenesis to

Anti-Inflammatory Diets Influencing IBD

16

chronic inflammation. This study focused more on the types of eicosanoids that are produced by
each type of fatty acid, and how they lead to, or inhibit, inflammation. As explained in the
previous section of this paper, the n-6 PUFA, arachidonic acid, is what stimulates the growth of
inflammatory eicosanoids, and the n-3 PUFAs, DHA and EPA, are arachidonic acid antagonists
(Calder & Grimble, 2002). A person can use this information to recognize that it is necessary to
meet the recommended amount of n-3 PUFAs each week to counteract the inflammatory effects
of arachidonic acid.
While dietary n-3s are mainly found in seafood, there are many people that do not
incorporate any seafood into their diet. Because of this, many people have studied the effects of
n-3 supplementation in order to create the correct balance of n-3s and n-6s that they are
consuming. A study done by Costenbader et al. in 2019 performed a randomized clinical trial to
study the effects of marine n-3 and vitamin D supplements. These trials were not able to find any
definitive positive effects of either supplement on biomarkers of systemic inflammation
(Costenbader et al., 2019). While this is the case, there were many flaws within this study that
were recognized, and which should be reviewed.
Despite the lack of findings, it is still a high possibility that n-3 supplements can be
beneficial for those who do not already include fish within their diet, and more randomized
control studies must be done to determine whether or not this is the case (McKinley, 2019).
There are also no known adverse health effects of these supplements which is why they are better
than no source of n-3s at all (McKinley, 2019).
Conclusion:
As described above, changing a person’s diet can ultimately change the way in which
their immunoregulatory cells function. While decreasing inflammation in the gut is not a cure for

Anti-Inflammatory Diets Influencing IBD

17

immune-mediated inflammatory diseases like IBD, it can greatly improve symptoms for people
diagnosed with this disease. The best way to use diet as a regulatory tool is to follow the AIP,
limit the consumption of poorly digested foods, and incorporate adequate n-3 PUFAS, while
limiting SFAs, in their daily meals. People who change their dietary patterns in this way are able
to incorporate more nutrient-dense foods and avoid foods that their body cannot tolerate. Each of
these changes has its own anti-inflammatory effect, and all together these changes create a
significant decrease in systemic inflammation. This can greatly improve chronic inflammation
and symptoms of IBD.
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